65 related articles for article (PubMed ID: 6697334)
1. Phase II study of PCNU in the treatment of head and neck carcinoma.
Dimery IW; Legha SS; Murphy WK; Moran ME; Stewart DJ; Goepfert H; Bodey GP
Cancer Treat Rep; 1984 Feb; 68(2):437-8. PubMed ID: 6697334
[No Abstract] [Full Text] [Related]
2. Phase II trial of PCNU in non-small cell lung cancer.
Kalman LA; Stoopler MB; Casper ES; Kelsen DP; Kris MG; Gralla RJ
Cancer Treat Rep; 1983 Sep; 67(9):837. PubMed ID: 6883361
[No Abstract] [Full Text] [Related]
3. Mitoguazone in advanced squamous cell carcinoma of head and neck origin: a phase II trial of the Southeastern Cancer Study Group.
Luedke DW; Maddox W; Birch R; Velez-Garcia E; Schleuter J
Cancer Treat Rep; 1986 Apr; 70(4):529-30. PubMed ID: 3698048
[No Abstract] [Full Text] [Related]
4. Phase II study of etoposide in previously untreated squamous cell carcinoma of the head and neck.
Cobleigh MA; Hill JH; Lad TE; Shevrin DE; Applebaum EL
Cancer Treat Rep; 1987 Mar; 71(3):321-2. PubMed ID: 3815398
[No Abstract] [Full Text] [Related]
5. Phase II trial of high-dose cytarabine and cisplatin in locoregional previously untreated squamous carcinoma of the head and neck: a Piedmont Oncology Association Study.
Craig JB; Powell BL; Jackson DV; Atkins JN; Smith LR; White DR; Richards F; Capizzi RL
Cancer Treat Rep; 1987 Feb; 71(2):151-3. PubMed ID: 3802112
[No Abstract] [Full Text] [Related]
6. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of mitoguazone in patients with advanced squamous cell carcinoma of the head and neck.
Perry DJ; Crain SM; Weltz MD; Wilson JP; Davis RK; Woolley PV; Forastiere AA; Taylor HG; Weiss RB
Cancer Treat Rep; 1983 Jan; 67(1):91-2. PubMed ID: 6616496
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of cystemustine in advanced head and neck cancer. A trial of the EORTC Clinical Screening Group.
Cappelaere P; Lentz MA; Degardin M; Chauvergne J; Mayer F; Chollet P; Chevallier B
Eur J Cancer B Oral Oncol; 1995 Mar; 31B(2):151-2. PubMed ID: 7633288
[No Abstract] [Full Text] [Related]
9. Induction chemotherapy with methotrexate, bleomycin and hydroxyurea with or without cisplatin in advanced squamous cell carcinoma of the head and neck: a study of the Swiss Group for Clinical Cancer Research (SAKK).
Abele R; Honegger HP; Wolfensberger M; Grossenbacher R; Mermillod B; Cavalli F
Prog Clin Biol Res; 1985; 201():169-75. PubMed ID: 2419916
[No Abstract] [Full Text] [Related]
10. Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck.
Pivot X; Raymond E; Laguerre B; Degardin M; Cals L; Armand JP; Lefebvre JL; Gedouin D; Ripoche V; Kayitalire L; Niyikiza C; Johnson R; Latz J; Schneider M
Br J Cancer; 2001 Sep; 85(5):649-55. PubMed ID: 11531245
[TBL] [Abstract][Full Text] [Related]
11. Phase II evaluation of mitolactol in squamous cell carcinoma of the head and neck: a Southeastern Cancer Study Group Trial.
McHale MS; Velez-Garcia E; Nelson O; Williams SD; Maddox W; Birch R
Cancer Treat Rep; 1986 Jul; 70(7):925-6. PubMed ID: 3521849
[No Abstract] [Full Text] [Related]
12. Treatment of previously untreated stage III and IV squamous cell carcinoma of the head and neck.
Hong WK; Shapshay SM
Otolaryngol Clin North Am; 1980; 13(3):521-8. PubMed ID: 6160448
[No Abstract] [Full Text] [Related]
13. Phase II trial of bisantrene in advanced epidermoid carcinoma of the head and neck.
Forastiere AA; Crain SM; Garbino C; Tipping SJ; Perry DJ; Kasdorf H; Van Echo DA
Cancer Treat Rep; 1984 Apr; 68(4):687-8. PubMed ID: 6713424
[No Abstract] [Full Text] [Related]
14. Phase II trial of vindesine in advanced squamous cell cancer of the head and neck.
Vogl SE; Camacho FJ; Kaplan BH; O'Donnell MR
Cancer Treat Rep; 1984 Mar; 68(3):559-60. PubMed ID: 6704987
[No Abstract] [Full Text] [Related]
15. Phase II trial of aclarubicin in epidermoid carcinoma of the head and neck.
Carugati AA; Olivari AJ; Campos DM; Pradier R; Woolley PV
Cancer Treat Rep; 1986 Jun; 70(6):799-800. PubMed ID: 3524828
[No Abstract] [Full Text] [Related]
16. Phase II trial of tiazofurin in recurrent squamous cell carcinoma of the head and neck.
Dimery IW; Neidhart JA; McCarthy K; Krakoff IH; Hong WK
Cancer Treat Rep; 1987 Apr; 71(4):425-6. PubMed ID: 3548960
[No Abstract] [Full Text] [Related]
17. Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390).
Forastiere AA; Shank D; Neuberg D; Taylor SG; DeConti RC; Adams G
Cancer; 1998 Jun; 82(11):2270-4. PubMed ID: 9610709
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of razoxane (ICRF-159) in patients with squamous cell carcinoma of the head and neck previously exposed to systemic chemotherapy.
Shah MK; Engstrom PF; Catalano RB; Paul AR; Bellet RE; Creech RH
Cancer Treat Rep; 1982 Mar; 66(3):557-8. PubMed ID: 7060043
[No Abstract] [Full Text] [Related]
19. Clinical studies with nitrosoureas in various solid tumors.
Slavik M
Cancer Treat Rep; 1976 Jun; 60(6):795-800. PubMed ID: 986243
[No Abstract] [Full Text] [Related]
20. Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study.
Schena M; Barone C; Birocco N; Dongiovanni D; Numico G; Colantonio I; Bertetto O
Cancer Chemother Pharmacol; 2005 Mar; 55(3):271-6. PubMed ID: 15592837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]